secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOMERICA INC (BMRA)
CIK:        0000073290
Form:       8-K
Filed at:   2023-08-28T23:59:59+00:00
Accession:  0001493152-23-030303
Event type: leadership
Sentiment:  positive
Materiality: 0.55
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Biomerica appoints former Meridian CEO Jack Kenny to Board of Directors
-----------------------------------------------------------------------

- Appointment effective August 25, 2023; Board expanded to add independent director.
- Kenny will chair Nominating and Corporate Governance Committee and serve on Audit Committee.
- Annual cash fee of $52,500 (paid quarterly); equity compensation to be determined later.
- Kenny previously led Meridian Bioscience as CEO, overseeing its $1.53B all-cash sale.
- Kenny to support launch of inFoods IBS test, which targets 40M+ U.S. IBS patients.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/73290/000149315223030303/0001493152-23-030303-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/73290/000149315223030303/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-030303

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer